Evolva
Duggingerstrasse 23
CH-4153 Reinach
+41 61 485 2000
ACTIVE CATEGORIES
Evolva solves the supply chain issues of nature through a 21st century mix of biotechnology and fermentation. We develop, make and sell ingredients that provide significant health, wellness and nutrition benefits to people in their daily life, but whose supply chain issues have limited their use until now. Our flagship ingredients are stevia, nootkatone and resveratrol. To make our world sustainable requires nature and technology to work together as one, and our aim is to play a (small) part in achieving this transformation. For more information seewww.evolva.com.
Products / Markets
Resveratrol: A matter of healthy ageing
Resveratrol (see alsohttp://veriteresveratrol.com/) is a polyphenol found in plants, peanuts, grapes, and berries to name a few.Â
There is a significant and growing body of evidence that has shown that resveratrol can produce a positive impact on the systems that decline with age like heart, bone, and brain. To date, some 10,000 studies have been published on resveratrol, with nearly 200 clinical studies.
Evolva’s resveratrol is the only resveratrol produced entirely by fermentation using yeast. It is made using natural and sustainable feedstocks and has a stable, traceable and reliable supply chain. Evolva’s resveratrol marks a major step forward for the category, which has been dominated by resveratrol sourced from China from the extract of polygonum (a.k.a. Japanese Knotweed). Our closed-system fermentation process avoids the possibility of environmental contaminants, such as emodin and PAHs, and provides the desired consistency and purity (>98%).
BUSINESS NEWS
26 Jan 2024 --- Lallemand Bio-Ingredients’ recent acquisition of Swiss biotechnology firm Evolva for a reported CHF20 million (∼US$23 million) will enable the company to produce complex... Read More
BUSINESS NEWS
08 Jan 2024 --- Industrial biotechnology leader Lallemand has acquired Swiss biotechnology firm Evolva for a reported CHF20 million (∼US$23.5 million) through its Swiss affiliate Danstar... Read More
BUSINESS NEWS
22 Dec 2023 --- Evolva Holding SA, a leader in natural molecules and industrial biotech, held an extraordinary general meeting (EGM) on December 21, 2023, where its shareholders approved a series... Read More
FOOD INGREDIENTS NEWS
15 Dec 2023 --- Lallemand’s Bio-Ingredients and Specialty Cultures divisions have teamed up to develop a new solution to reduce or remove the need for added nitrates and nitrites in processed... Read More
FOOD RESEARCH
26 Oct 2023 --- Researchers from the University of Minnesota and Brightseed are spotlighting more reasons to prioritize fiber in our regular diets. The study reveals that each plant source of... Read More
23 Jan 2024 --- Lallemand Bio-Ingredients president and general manager Lars Asferg unravels the potential in the company’s recent acquisition of Swiss biotechnology firm Evolva. Asferg discusses how Evolva’s precision fermentation tech could boost Lallemand’s health and flavor and fragrance businesses. He also outlines the business unit’s key focuses for 2024.